Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Characterization of Collagen/Lipid Nanoparticle-Curcumin Cryostructurates for Wound Healing Applications.

Laghezza Masci V, Taddei AR, Courant T, Tezgel O, Navarro F, Giorgi F, Mariolle D, Fausto AM, Texier I.

Macromol Biosci. 2019 May;19(5):e1800446. doi: 10.1002/mabi.201800446. Epub 2019 Feb 15.

PMID:
30768756
2.

Measuring Particle Size Distribution by Asymmetric Flow Field Flow Fractionation: A Powerful Method for the Preclinical Characterization of Lipid-Based Nanoparticles.

Caputo F, Arnould A, Bacia M, Ling WL, Rustique E, Texier I, Mello AP, Couffin AC.

Mol Pharm. 2019 Feb 4;16(2):756-767. doi: 10.1021/acs.molpharmaceut.8b01033. Epub 2019 Jan 16.

3.

Lipid Nanoparticles and Their Hydrogel Composites for Drug Delivery: A Review.

Desfrançois C, Auzély R, Texier I.

Pharmaceuticals (Basel). 2018 Nov 1;11(4). pii: E118. doi: 10.3390/ph11040118. Review.

4.

Comparative analysis of nanosystems' effects on human endothelial and monocytic cell functions.

Matuszak J, Dörfler P, Lyer S, Unterweger H, Juenet M, Chauvierre C, Alaarg A, Franke D, Almer G, Texier I, Metselaar JM, Prassl R, Alexiou C, Mangge H, Letourneur D, Cicha I.

Nanotoxicology. 2018 Nov;12(9):957-974. doi: 10.1080/17435390.2018.1502375. Epub 2018 Sep 28.

PMID:
30265172
5.

From design to the clinic: practical guidelines for translating cardiovascular nanomedicine.

Cicha I, Chauvierre C, Texier I, Cabella C, Metselaar JM, Szebeni J, Dézsi L, Alexiou C, Rouzet F, Storm G, Stroes E, Bruce D, MacRitchie N, Maffia P, Letourneur D.

Cardiovasc Res. 2018 Nov 1;114(13):1714-1727. doi: 10.1093/cvr/cvy219.

PMID:
30165574
6.

Chitosan-lipid nanoparticles (CS-LNPs): Application to siRNA delivery.

Tezgel Ö, Szarpak-Jankowska A, Arnould A, Auzély-Velty R, Texier I.

J Colloid Interface Sci. 2018 Jan 15;510:45-56. doi: 10.1016/j.jcis.2017.09.045. Epub 2017 Sep 11.

PMID:
28934610
7.

Time-Controllable Lipophilic-Drug Release System Designed by Loading Lipid Nanoparticles into Polysaccharide Hydrogels.

Racine L, Guliyeva A, Wang I, Larreta-Garde V, Auzély-Velty R, Texier I.

Macromol Biosci. 2017 Sep;17(9). doi: 10.1002/mabi.201700045. Epub 2017 Jul 3.

PMID:
28671768
8.

Design of interpenetrating chitosan and poly(ethylene glycol) sponges for potential drug delivery applications.

Racine L, Costa G, Bayma-Pecit E, Texier I, Auzély-Velty R.

Carbohydr Polym. 2017 Aug 15;170:166-175. doi: 10.1016/j.carbpol.2017.04.060. Epub 2017 Apr 25.

PMID:
28521983
9.

Nanoparticles for intravascular applications: physicochemical characterization and cytotoxicity testing.

Matuszak J, Baumgartner J, Zaloga J, Juenet M, da Silva AE, Franke D, Almer G, Texier I, Faivre D, Metselaar JM, Navarro FP, Chauvierre C, Prassl R, Dézsi L, Urbanics R, Alexiou C, Mangge H, Szebeni J, Letourneur D, Cicha I.

Nanomedicine (Lond). 2016 Mar;11(6):597-616. doi: 10.2217/nnm.15.216. Epub 2016 Mar 22.

10.

An MRI-based classification scheme to predict passive access of 5 to 50-nm large nanoparticles to tumors.

Karageorgis A, Dufort S, Sancey L, Henry M, Hirsjärvi S, Passirani C, Benoit JP, Gravier J, Texier I, Montigon O, Benmerad M, Siroux V, Barbier EL, Coll JL.

Sci Rep. 2016 Feb 19;6:21417. doi: 10.1038/srep21417.

11.

Phase-0/phase-I study of dye-loaded lipid nanoparticles for near-infrared fluorescence imaging in healthy dogs.

Sayag D, Cabon Q, Texier I, Navarro FP, Boisgard R, Virieux-Watrelot D, Carozzo C, Ponce F.

Eur J Pharm Biopharm. 2016 Mar;100:85-93. doi: 10.1016/j.ejpb.2016.01.001. Epub 2016 Jan 8.

PMID:
26777342
12.

Evaluation of intraoperative fluorescence imaging-guided surgery in cancer-bearing dogs: a prospective proof-of-concept phase II study in 9 cases.

Cabon Q, Sayag D, Texier I, Navarro F, Boisgard R, Virieux-Watrelot D, Ponce F, Carozzo C.

Transl Res. 2016 Apr;170:73-88. doi: 10.1016/j.trsl.2015.12.001. Epub 2015 Dec 19.

PMID:
26746803
13.

Comparative biodistribution in mice of cyanine dyes loaded in lipid nanoparticles.

Mérian J, Boisgard R, Bayle PA, Bardet M, Tavitian B, Texier I.

Eur J Pharm Biopharm. 2015 Jun;93:1-10. doi: 10.1016/j.ejpb.2015.03.019. Epub 2015 Mar 21.

PMID:
25805562
14.

FRET imaging approaches for in vitro and in vivo characterization of synthetic lipid nanoparticles.

Gravier J, Sancey L, Hirsjärvi S, Rustique E, Passirani C, Benoît JP, Coll JL, Texier I.

Mol Pharm. 2014 Sep 2;11(9):3133-44. doi: 10.1021/mp500329z. Epub 2014 Aug 13.

PMID:
25098740
15.

Preparation and characterization of mTHPC-loaded solid lipid nanoparticles for photodynamic therapy.

Navarro FP, Creusat G, Frochot C, Moussaron A, Verhille M, Vanderesse R, Thomann JS, Boisseau P, Texier I, Couffin AC, Barberi-Heyob M.

J Photochem Photobiol B. 2014 Jan 5;130:161-9. doi: 10.1016/j.jphotobiol.2013.11.007. Epub 2013 Nov 21.

PMID:
24333764
16.

Synthetic lipid nanoparticles targeting steroid organs.

Mérian J, Boisgard R, Decleves X, Thezé B, Texier I, Tavitian B.

J Nucl Med. 2013 Nov;54(11):1996-2003. doi: 10.2967/jnumed.113.121657. Epub 2013 Sep 26.

17.

LipImage™ 815: novel dye-loaded lipid nanoparticles for long-term and sensitive in vivo near-infrared fluorescence imaging.

Jacquart A, Kéramidas M, Vollaire J, Boisgard R, Pottier G, Rustique E, Mittler F, Navarro FP, Boutet J, Coll JL, Texier I.

J Biomed Opt. 2013 Oct;18(10):101311. doi: 10.1117/1.JBO.18.10.101311.

PMID:
23900442
18.

Bone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formation.

Levet S, Ciais D, Merdzhanova G, Mallet C, Zimmers TA, Lee SJ, Navarro FP, Texier I, Feige JJ, Bailly S, Vittet D.

Blood. 2013 Jul 25;122(4):598-607. doi: 10.1182/blood-2012-12-472142. Epub 2013 Jun 5.

19.

Detection of brain tumors using fluorescence diffuse optical tomography and nanoparticles as contrast agents.

Fortin PY, Genevois C, Koenig A, Heinrich E, Texier I, Couillaud F.

J Biomed Opt. 2012 Dec;17(12):126004. doi: 10.1117/1.JBO.17.12.126004.

PMID:
23208215
20.

Influence of size, surface coating and fine chemical composition on the in vitro reactivity and in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions in cancer models.

Hirsjärvi S, Dufort S, Gravier J, Texier I, Yan Q, Bibette J, Sancey L, Josserand V, Passirani C, Benoit JP, Coll JL.

Nanomedicine. 2013 Apr;9(3):375-87. doi: 10.1016/j.nano.2012.08.005. Epub 2012 Sep 6.

PMID:
22960195

Supplemental Content

Loading ...
Support Center